Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

<h4>Background</h4>The European rivaroxaban post-authorization safety study evaluated bleeding risk among patients initiated on rivaroxaban or vitamin K antagonists for the treatment and secondary prevention of venous thromboembolism in routine clinical practice.<h4>Methods</h4&...

Full description

Bibliographic Details
Main Authors: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298596&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298596&type=printable

Similar Items